We are live on ! Find out more
LC

Lindbrook Capital Portfolio holdings

AUM $1.08B
1-Year Est. Return 10.14%
This Fund
S&P 500
This Quarter Est. Return
+7.83%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
–
AUM
$853M
AUM Growth
+$41.2M
Cap. Flow
-$4.27M
Cap. Flow %
-0.5%
Top 10 Hldgs %
45.97%
Holding
2,993
New
166
Increased
1,040
Reduced
961
Closed
220

Top Buys

Rank Stock Value
1
VXUS icon
Vanguard Total International Stock ETF
VXUS
+$12.7M
2
RPAR icon
RPAR Risk Parity ETF
RPAR
+$5.28M
3
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$4.15M
4
BAC icon
Bank of America
BAC
+$4.06M
5
NVDA icon
NVIDIA
NVDA
+$3.33M

Top Sells

Rank Stock Value
1
ORMP icon
Oramed Pharmaceuticals
ORMP
+$4.61M
2
DBC icon
Invesco DB Commodity Index Tracking Fund
DBC
+$4.54M
3
FTGC icon
First Trust Global Tactical Commodity Strategy Fund
FTGC
+$4.45M
4
IEO icon
iShares US Oil & Gas Exploration & Production ETF
IEO
+$4.15M
5
AGEN
Agenus
AGEN
+$2.89M

Sector Composition

Rank Sector Weight
1 Financials 17.04%
2 Technology 13.3%
3 Healthcare 7.37%
4 Industrials 3.43%
5 Consumer Staples 3.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HOPE icon
2201
Hope Bancorp
HOPE
$1.79B
$2.22K ﹤0.01%
226
– –
BCRX icon
2202
BioCryst Pharmaceuticals
BCRX
$2.4B
$2.21K ﹤0.01%
265
+49
+23% +$472
LESL icon
2203
Leslie's
LESL
$11M
$2.2K ﹤0.01%
10
+3
+43% +$779
DQ
2204
Daqo New Energy
DQ
$996M
$2.2K ﹤0.01%
47
-104
-69% -$4.78K
AGIO icon
2205
Agios Pharmaceuticals
AGIO
$1.93B
$2.18K ﹤0.01%
95
-54
-36% -$1.43K
SAGE
2206
DELISTED
Sage Therapeutics
SAGE
$2.18K ﹤0.01%
52
-4
-7% -$172
ASIX icon
2207
AdvanSix
ASIX
$444M
$2.18K ﹤0.01%
57
– –
ADAM
2208
Adamas Trust
ADAM
$883M
$2.18K ﹤0.01%
219
-283
-56% -$3.07K
MWA icon
2209
Mueller Water Products
MWA
$4.16B
$2.17K ﹤0.01%
156
– –
FLNA
2210
Filana Therapeutics
FLNA
$48.1M
$2.17K ﹤0.01%
90
-319
-78% -$8.84K
MYE icon
2211
Myers Industries
MYE
$1.29B
$2.16K ﹤0.01%
101
-9
-8% -$205
LBTYK icon
2212
Liberty Global Class C
LBTYK
$3.49B
$2.16K ﹤0.01%
106
– –
BLMN icon
2213
Bloomin' Brands
BLMN
$938M
$2.15K ﹤0.01%
84
-22
-21% -$547
UFPI icon
2214
UFP Industries
UFPI
$5.19B
$2.15K ﹤0.01%
27
+15
+125% +$1.28K
BRY
2215
DELISTED
Berry Corp
BRY
$2.14K ﹤0.01%
273
+132
+94% +$1.14K
JAMF
2216
DELISTED
Jamf
JAMF
$2.14K ﹤0.01%
110
-6
-5% -$120
RNAM
2217
DELISTED
Avidity Biosciences
RNAM
$2.13K ﹤0.01%
139
-9
-6% -$198
SGI
2218
Somnigroup International
SGI
$13.7B
$2.13K ﹤0.01%
54
– –
ALKT icon
2219
Alkami Technology
ALKT
$2.11B
$2.13K ﹤0.01%
168
-87
-34% -$1.28K
FBMS
2220
DELISTED
The First Bancshares, Inc.
FBMS
$2.12K ﹤0.01%
82
-75
-48% -$2.21K
INVA icon
2221
Innoviva
INVA
$1.48B
$2.12K ﹤0.01%
188
+91
+94% +$1.1K
OCUL icon
2222
Ocular Therapeutix
OCUL
$2.02B
$2.11K ﹤0.01%
+401
New +$1.9K
EHC icon
2223
Encompass Health
EHC
$12.4B
$2.11K ﹤0.01%
+39
New +$2.27K
RLAY icon
2224
Relay Therapeutics
RLAY
$4.33B
$2.11K ﹤0.01%
128
+116
+967% +$2.08K
OSH
2225
DELISTED
Oak Street Health, Inc.
OSH
$2.09K ﹤0.01%
54
– –
87 88
89
90 91

Similar funds

SBIA
Sheaff Brock Investment Advisors Indianapolis, Indiana $1.09B AUM 14.4% 1-Year Est. Return
CHP
Cable Hill Partners Portland, Oregon $1.02B AUM 8.59% 1-Year Est. Return
MW
Marcum Wealth Cleveland, Ohio $1.16B AUM 6.7% 1-Year Est. Return
TAM
Taurus Asset Management New York $986M AUM 5.04% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.72% 1-Year Est. Return
CIG
CCM Investment Group Northfield, Minnesota $946M AUM
CCM
CAAS Capital Management New York $934M AUM 1.45% 1-Year Est. Return
WCF
West Coast Financial Santa Barbara, California $876M AUM 5.74% 1-Year Est. Return

Lindbrook Capital's Q1 2023 Portfolio in Review

As of Q1 2023, Lindbrook Capital held 2,993 positions worth $853M, up 5.1% from $812M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Lindbrook Capital's Q1 2023 filing shows 166 new, 1,040 increased, 961 reduced and 220 closed positions. Its largest new stake was Hess Midstream: 4,984 shares worth $144K. The largest sale was Oramed Pharmaceuticals, an estimated $4.61M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 18% a quarter earlier, followed by Technology and Healthcare.

  • Lindbrook Capital's largest Q1 2023 buy was Hess Midstream: 4,984 shares worth $144K.
  • Lindbrook Capital added most to Vanguard Total International Stock ETF in Q1 2023, an estimated $12.7M increase.
  • Lindbrook Capital's biggest Q1 2023 reduction was Agenus, cutting an estimated $2.89M.
  • Lindbrook Capital fully exited Oramed Pharmaceuticals in Q1 2023, selling an estimated $4.61M.
  • Lindbrook Capital's ten largest holdings make up 46% of its $853M portfolio in Q1 2023.
  • Lindbrook Capital opened 166 new positions and closed 220 in Q1 2023.
  • Lindbrook Capital's portfolio value rose 5.1% quarter-over-quarter to $853M.

Based on Lindbrook Capital's 13F filing for Q1 2023, filed 26 Apr 2023.